Hans-Jochem Kolb
Overview
Explore the profile of Hans-Jochem Kolb including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
99
Citations
2718
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Donor lymphocyte infusions in adolescents and young adults for control of advanced pediatric sarcoma
Schober S, von Luettichau I, Wawer A, Steinhauser M, Salat C, Schwinger W, et al.
Oncotarget
. 2018 Jun;
9(32):22741-22748.
PMID: 29854312
Background: Allogeneic stem cell transplantation (allo-SCT) and donor lymphocyte infusions (DLI) may induce a graft-versus-tumor effect in pediatric sarcoma patients. Here, we describe general feasibility, toxicity and efficacy of DLI...
12.
Ansprenger C, Vogt V, Schick J, Hirn-Lopez A, Vokac Y, Harabacz I, et al.
Cell Immunol
. 2018 Mar;
328:33-48.
PMID: 29580554
Introduction: Paramunity-inducing-Factors (PINDs) consist of attenuated/inactivated viruses of various poxvirus-genera, used in veterinary medicine as non-antigen-specific, non-immunising stimulators of the innate immune system against infectious and malignant diseases. Their danger-signaling-interactions...
13.
Brissot E, Labopin M, Stelljes M, Ehninger G, Schwerdtfeger R, Finke J, et al.
J Hematol Oncol
. 2017 Jun;
10(1):130.
PMID: 28646908
Background: Primary refractory acute myeloid leukemia (PRF-AML) is associated with a dismal prognosis. Allogeneic stem cell transplantation (HSCT) in active disease is an alternative therapeutic strategy. The increased availability of...
14.
Fischbacher D, Merle M, Liepert A, Grabrucker C, Kroell T, Kremser A, et al.
Cell Commun Adhes
. 2016 Sep;
22(2-6):49-65.
PMID: 27602789
To enlighten interactions between autologous, allogeneic or T-cells from patients after stem cell transplantation with leukaemia-derived-dendritic-cells containing dendritic cells or blast containing mononuclear cells (n = 21, respectively), we determined...
15.
Thiel U, Wawer A, von Luettichau I, Bender H, Blaeschke F, Grunewald T, et al.
Oncotarget
. 2016 Aug;
7(43):70959-70968.
PMID: 27486822
Purpose: Advanced Ewing sarcomas have poor prognosis. They are defined by early relapse (<24 months after diagnosis) and/or by metastasis to multiple bones or bone marrow (BM). We analyzed risk...
16.
17.
Reinwald M, Schleyer E, Kiewe P, Blau I, Burmeister T, Pursche S, et al.
Biomed Res Int
. 2014 Jul;
2014:637059.
PMID: 25025064
Central nervous system (CNS) involvement is a severe complication of BCR-ABL-positive leukemia after allogenic stem cell transplantation (alloSCT) associated with fatal outcome. Although second-generation tyrosine-kinase inhibitors (TKI) such as nilotinib...
18.
Pfirrmann M, Saussele S, Hochhaus A, Reiter A, Berger U, Hossfeld D, et al.
J Cancer Res Clin Oncol
. 2014 Apr;
140(8):1367-81.
PMID: 24718719
Purpose: In the two consecutive German studies III and IIIA on chronic myeloid leukemia, between 1995 and 2004, 781 patients were randomized to receive either allogeneic hematopoietic stem cell transplantation...
19.
Steger B, Milosevic S, Doessinger G, Reuther S, Liepert A, Braeu M, et al.
Immunobiology
. 2013 Dec;
219(4):247-60.
PMID: 24315637
T-cells play an important role in the remission-maintenance in AML-patients (pts) after SCT, however the role of LAA- (WT1, PR1, PRAME) or minor-histocompatibility (mHag, HA1) antigen-specific CD4(+) and CD8(+)T-cells is...
20.
Hehlmann R, Muller M, Lauseker M, Hanfstein B, Fabarius A, Schreiber A, et al.
J Clin Oncol
. 2013 Dec;
32(5):415-23.
PMID: 24297946
Purpose: Deep molecular response (MR(4.5)) defines a subgroup of patients with chronic myeloid leukemia (CML) who may stay in unmaintained remission after treatment discontinuation. It is unclear how many patients...